UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Integrated Resistance Analysis of CERTAIN-1 and CERTAIN-2 Studies in Hepatitis C Virus-Infected Patients Receiving Glecaprevir and Pibrentasvir in Japan

Antimicrobial agents and chemotherapy, 2018-02, Vol.62 (2)

2018

Volltextzugriff (PDF)

Slower saccadic reading in Parkinson's disease

PloS one, 2018-01, Vol.13 (1), p.e0191005-e0191005

2018

Volltextzugriff (PDF)

Hepatitis C virus genetic diversity by geographic region within genotype 1-6 subtypes among patients treated with glecaprevir and pibrentasvir

PloS one, 2018-10, Vol.13 (10), p.e0205186

2018

Volltextzugriff (PDF)

Synthesis and Biological Characterization of Aryl Uracil Inhibitors of Hepatitis C Virus NS5B Polymerase: Discovery of ABT-072, a trans-Stilbene Analog with Good Oral Bioavailability

Journal of medicinal chemistry, 2018-02, Vol.61 (3), p.1153-1163

2018

Volltextzugriff (PDF)

In Vitro Antibacterial Potency and Spectrum of ABT-492, a New Fluoroquinolone

Antimicrobial Agents and Chemotherapy, 2003-10, Vol.47 (10), p.3260-3269

2003

Volltextzugriff (PDF)

Resistance Analysis of a 3-Day Monotherapy Study with Glecaprevir or Pibrentasvir in Patients with Chronic Hepatitis C Virus Genotype 1 Infection

Viruses, 2018-08, Vol.10 (9), p.462

2018

Volltextzugriff (PDF)

Aryl uracil inhibitors of hepatitis C virus NS5B polymerase: Synthesis and characterization of analogs with a fused 5,6-bicyclic ring motif

Bioorganic & medicinal chemistry letters, 2013-06, Vol.23 (12), p.3487-3490

2013

Volltextzugriff (PDF)

Comparison of In Vitro Activities of ABT-773 and Telithromycin against Macrolide-Susceptible and -Resistant Streptococci and Staphylococci

Antimicrobial Agents and Chemotherapy, 2002-03, Vol.46 (3), p.783-786

2002

Volltextzugriff (PDF)

Community-Based Surveillance in the United States of Macrolide-Resistant Pediatric Pharyngeal Group A Streptococci during 3 Respiratory Disease Seasons

Clinical infectious diseases, 2004-12, Vol.39 (12), p.1794-1801

2004

Volltextzugriff (PDF)

In Vitro Antiviral Activity and Resistance Profile of the Next-Generation Hepatitis C Virus NS5A Inhibitor Pibrentasvir

Antimicrobial agents and chemotherapy, 2017-05, Vol.61 (5)

2017

Volltextzugriff (PDF)

Resistance analysis of baseline and treatment-emergent variants in hepatitis C virus genotype 1 in the AVIATOR study with paritaprevir-ritonavir, ombitasvir, and dasabuvir

Antimicrobial agents and chemotherapy, 2015-09, Vol.59 (9), p.5445-5454

2015

Volltextzugriff (PDF)

In vitro and in vivo antiviral activity and resistance profile of ombitasvir, an inhibitor of hepatitis C virus NS5A

Antimicrobial agents and chemotherapy, 2015-02, Vol.59 (2), p.979-987

2015

Volltextzugriff (PDF)

Antimicrobial Susceptibilities of Invasive Pediatric Abiotrophia and Granulicatella Isolates

Journal of Clinical Microbiology, 2004-09, Vol.42 (9), p.4323-4326

2004

Volltextzugriff (PDF)

Prevalence of Macrolide Resistance Mechanisms in Streptococcus pneumoniae Isolates from a Multicenter Antibiotic Resistance Surveillance Study Conducted in the United States in 1994–1995

Clinical infectious diseases, 1999-11, Vol.29 (5), p.1186-1188

1999

Volltextzugriff (PDF)

In Vitro Antiviral Activity and Resistance Profile of the Next-Generation Hepatitis C Virus NS3/4A Protease Inhibitor Glecaprevir

Antimicrobial agents and chemotherapy, 2018-01, Vol.62 (1)

2018

Volltextzugriff (PDF)

Pooled Resistance Analysis in Patients with Hepatitis C Virus Genotype 1 to 6 Infection Treated with Glecaprevir-Pibrentasvir in Phase 2 and 3 Clinical Trials

Antimicrobial agents and chemotherapy, 2018-10, Vol.62 (10)

2018

Volltextzugriff (PDF)

Comparison of emm Typing and Ribotyping with Three Restriction Enzymes To Characterize Clinical Isolates of Streptococcus pyogenes

Journal of Clinical Microbiology, 2005, Vol.43 (1), p.150-155

2005

Volltextzugriff (PDF)

Hepatitis C virus genotype 4 resistance and subtype demographic characterization of patients treated with ombitasvir plus paritaprevir/ritonavir

Antimicrobial agents and chemotherapy, 2015-11, Vol.59 (11), p.6807-6815

2015

Volltextzugriff (PDF)

Molecular Epidemiology of Macrolide Resistance in Neonatal Bloodstream Isolates of Group B Streptococci

Journal of Clinical Microbiology, 2003-06, Vol.41 (6), p.2659-2661

2003

Volltextzugriff (PDF)

Analysis of Hepatitis C Virus Genotype 1b Resistance Variants in Japanese Patients Treated with Paritaprevir-Ritonavir and Ombitasvir

Antimicrobial agents and chemotherapy, 2016-02, Vol.60 (2), p.1106-1113

2016

Volltextzugriff (PDF)

Antimicrobial susceptibility and molecular characterization of community-acquired methicillin-resistant Staphylococcus aureus

Diagnostic microbiology and infectious disease, 2002-07, Vol.43 (3), p.225-232

2002

Volltextzugriff (PDF)

Density and distribution of dendritiform cells in the peripheral cornea of healthy subjects using in vivo confocal microscopy

The ocular surface, 2022-10, Vol.26, p.157-165

2022

Volltextzugriff (PDF)

Epidemiology of macrolide and/or lincosamide resistant Streptococcus pneumoniae clinical isolates with ribosomal mutations

Diagnostic microbiology and infectious disease, 2004-05, Vol.49 (1), p.47-52

2004

Volltextzugriff (PDF)

Prevention of visually debilitating deposits on soft contact lenses in keratoprosthesis patients

Cornea, 2011-12, Vol.30 (12), p.1419-1422

2011

Volltextzugriff (PDF)

Novel mechanism of macrolide resistance in Streptococcus pneumoniae

Diagnostic microbiology and infectious disease, 1996-10, Vol.26 (2), p.73-78

1996

Volltextzugriff (PDF)

1 – 25 von 62

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(57)
Mit Volltextzugriff
(51)

Publikationsform

Artikel
(58)
magazinearticle
(4)

Sprache

Englisch
(62)
Japanisch
(12)

Erscheinungsjahr

n.n

Thema

Science & Technology
(45)
Life Sciences & Biomedicine
(43)
Humans
(34)
Microbiology
(25)
Biological And Medical Sciences
(18)
Pharmacology & Pharmacy
(18)
Medical Sciences
(14)
Infectious Diseases
(13)
Antiviral Agents
(10)
Genotype
(10)
Hepacivirus - Drug Effects
(10)
Male
(10)
Microbial Sensitivity Tests
(10)
Pharmacology. Drug Treatments
(10)
Anti-Bacterial Agents - Pharmacology
(9)
Antibiotics. Antiinfectious Agents. Antiparasitic Agents
(9)
Female
(9)
Hepacivirus - Genetics
(9)
Hepatitis C Virus
(9)
Animals
(8)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Integrated Resistance Analysis of CERTAIN-1 and CERTAIN-2 Studies in Hepatitis C Virus-Infected Patients Receiving Glecaprevir and Pibrentasvir in Japan

Slower saccadic reading in Parkinson's disease

Hepatitis C virus genetic diversity by geographic region within genotype 1-6 subtypes among patients treated with glecaprevir and pibrentasvir

Synthesis and Biological Characterization of Aryl Uracil Inhibitors of Hepatitis C Virus NS5B Polymerase: Discovery of ABT-072, a trans-Stilbene Analog with Good Oral Bioavailability

In Vitro Antibacterial Potency and Spectrum of ABT-492, a New Fluoroquinolone

Resistance Analysis of a 3-Day Monotherapy Study with Glecaprevir or Pibrentasvir in Patients with Chronic Hepatitis C Virus Genotype 1 Infection

Aryl uracil inhibitors of hepatitis C virus NS5B polymerase: Synthesis and characterization of analogs with a fused 5,6-bicyclic ring motif

Comparison of In Vitro Activities of ABT-773 and Telithromycin against Macrolide-Susceptible and -Resistant Streptococci and Staphylococci

Community-Based Surveillance in the United States of Macrolide-Resistant Pediatric Pharyngeal Group A Streptococci during 3 Respiratory Disease Seasons

In Vitro Antiviral Activity and Resistance Profile of the Next-Generation Hepatitis C Virus NS5A Inhibitor Pibrentasvir

Resistance analysis of baseline and treatment-emergent variants in hepatitis C virus genotype 1 in the AVIATOR study with paritaprevir-ritonavir, ombitasvir, and dasabuvir

In vitro and in vivo antiviral activity and resistance profile of ombitasvir, an inhibitor of hepatitis C virus NS5A

Antimicrobial Susceptibilities of Invasive Pediatric Abiotrophia and Granulicatella Isolates

Prevalence of Macrolide Resistance Mechanisms in Streptococcus pneumoniae Isolates from a Multicenter Antibiotic Resistance Surveillance Study Conducted in the United States in 1994–1995

In Vitro Antiviral Activity and Resistance Profile of the Next-Generation Hepatitis C Virus NS3/4A Protease Inhibitor Glecaprevir

Pooled Resistance Analysis in Patients with Hepatitis C Virus Genotype 1 to 6 Infection Treated with Glecaprevir-Pibrentasvir in Phase 2 and 3 Clinical Trials

Comparison of emm Typing and Ribotyping with Three Restriction Enzymes To Characterize Clinical Isolates of Streptococcus pyogenes

Hepatitis C virus genotype 4 resistance and subtype demographic characterization of patients treated with ombitasvir plus paritaprevir/ritonavir

Molecular Epidemiology of Macrolide Resistance in Neonatal Bloodstream Isolates of Group B Streptococci

Analysis of Hepatitis C Virus Genotype 1b Resistance Variants in Japanese Patients Treated with Paritaprevir-Ritonavir and Ombitasvir

Antimicrobial susceptibility and molecular characterization of community-acquired methicillin-resistant Staphylococcus aureus

Density and distribution of dendritiform cells in the peripheral cornea of healthy subjects using in vivo confocal microscopy

Epidemiology of macrolide and/or lincosamide resistant Streptococcus pneumoniae clinical isolates with ribosomal mutations

Prevention of visually debilitating deposits on soft contact lenses in keratoprosthesis patients

Novel mechanism of macrolide resistance in Streptococcus pneumoniae

Suchergebnisse filtern